Category Archives: U.S. Policy and Funding

Fewer than a quarter of airplane passengers traveling to countries where yellow fever is endemic were required to show proof of vaccination against the disease upon arrival, when they were traveling from countries where the disease is not transmitted locally, according to a report released this week by the World Health Organization. The finding, the […]

Global infectious diseases responses not addressed Mike Pompeo’s hearing, testimony for Secretary of State confirmation President Trump applauded the confirmation of Mike Pompeo as the new Secretary of State Thursday, saying “He will always put the interests of America first.” In the view of many, including at least his three most recent predecessors, that would […]

The following is a guest post by Scott Moreland, PhD of MEASURE Evaluation Recent experience with the threat of Ebola Virus Disease in West Africa, specifically Guinea, has rung a few bells in neighboring Senegal. Approximately 75 percent of new infectious diseases that threaten people have been shown to be zoonotic—that is, originating from animals […]

The idea of pairing responses to diseases found in the global south that are so neglected that they are classified by that word with the better-funded, but still constrained responses to the so-called “Big Three” of HIV, tuberculosis and malaria, was not new. Neither was the hope that those combined efforts could streamline infectious disease control […]

Three patients with post-operative infections reported by New York Health officials in May 2017 to the U.S. Centers for Disease Control and Prevention sparked an investigation that revealed 35 more patients from nine states who had traveled to the Dominican Republic for cosmetic procedures and returned with nontuberculosis myobacteria. The investigation led to the temporary […]

The spending bill for 2018 passed in the House Thursday, and the Senate early today has delivered a robust rejection of the President’s proposals to slash science spending while massively cutting funds for global infectious disease responses, with a combination of level funding and a few notable raises. They include with a $3 billion boost for […]

Plan ahead . . . FDA-approved shot is unavailable, and with limited availability of alternative vaccine, getting inoculated may be a journey in itself . . . Following 10 cases of yellow fever linked to travel in Brazil that led to four deaths this year so far, the U.S. Centers for Disease Control and Prevention has […]

About six months ago, the World Health Organization and the U.S. Centers for Disease Control and Prevention brought together researchers, ministries of health staff, global health program and policy leaders, and experts in pox viruses to discuss re-emergence of a disease that has been reported in more countries during the last decade than in the […]

The selection of San Francisco and Oakland to host the 23rd International AIDS Conference in 2020 speaks to the power of activism over despair, of science over fear, and of ambition over acceptance — at least to some of those, including Congressional representatives, advocacy organizations, and service providers, cheering the announcement released Tuesday. Or it […]

The following is a guest post by Jessica Fehringer, PhD, MEASURE Evaluation I’ve worked in research and with researchers for a while, and often I hear people say that it doesn’t make sense to address gender in their research. When we think about science, we think about proving or disproving a hypothesis. In other words, […]